2011•Xiandai yufang yixueRequires access

ISOLATION AND ANTIMICROBIAL DRUG CHOICE OF ESCHERICHIA COLI IN URINARY TRACT INFECTION

Wang Ming-yon

Open publisher page 0 citations

Abstract

[Objective]To understand the epidemic of Escherichia Coli in the urinary tract infection and it's sensitivity to 14 antibiotics,and to provide references for the clinical application of drugs.[Methods]128 strains Escherichia Coli infected urinary samples which were collected from 2008 to 2009 were carried out K-B method susceptibility test and ESBLs test.[Results]A total of 355 strains of the clinical isolates were isolated from 1 029 cases of urine samples.128 strains of them were the E.coli,and 65 producing ESBL bacteria was detected in 128 E.coli.It's positive rate was 50.8%.The best effect of killing bacteria was Imipenem.It's susceptibility was 100%,the secondly was Amikcacin(81.5%).[Conclusion]Escherichia coli is the most common clinical isolates of urine specimen,and the multidrug resistance was serious in the producing ESBL bacterias.Imipenem should be applied firstly in the treatment to the infection of the producing ESBL bacteria.

About this research paper

What this paper is about

[Objective]To understand the epidemic of Escherichia Coli in the urinary tract infection and it's sensitivity to 14 antibiotics,and to provide references for the clinical application of drugs.[Methods]128 strains Escherichia Coli infected urinary samples which were collected from 2008 to 2009 were carried out K-B method susceptibility test and ESBLs test.[Results]A total of 355 strains of the clinical isolates were isolated from 1 029 cases of urine samples.128 strains of them were the E.coli,and 65 producing ESBL bacteria was detected in 128 E.coli.It's positive rate was 50.8%.The best effect of killing bacteria was Imipenem.It's susceptibility was 100%,the secondly was Amikcacin(81.5%).[Conclusion]Escherichia coli is the most common clinical isolates of urine specimen,and the multidrug resistance was serious in the producing ESBL bacterias.Imipenem should be applied firstly in the treatment to the infection of the producing ESBL bacteria.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective]To understand the epidemic of Escherichia Coli in the urinary tract infection and it's sensitivity to 14 antibiotics,and to provide references for the clinical application of drugs.[Methods]128 strains Escherichia Coli infected urinary samples which were collected from 2008 to 2009 were carried out K-B method susceptibility test and ESBLs test.[Results]A total of 355 strains of the clinical isolates were isolated from 1 029 cases of urine samples.128 strains of them were the E.coli,and 65 producing ESBL bacteria was detected in 128 E.coli.It's positive rate was 50.8%.The best effect of killing bacteria was Imipenem.It's susceptibility was 100%,the secondly was Amikcacin(81.5%).[Conclusion]Escherichia coli is the most common clinical isolates of urine specimen,and the multidrug resistance was serious in the producing ESBL bacterias.Imipenem should be applied firstly in the treatment to the infection of the producing ESBL bacteria.

Key concepts: Imipenem, Escherichia coli, Microbiology, Urine, Bacteria, Antibiotics, Urinary system, Drug resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
ISOLATION AND ANTIMICROBIAL DRUG CHOICE OF ESCHERICHIA COLI IN URINARY TRACT INFECTION — Research Paper | ScholarLens